Health Discovery Corporation (HDVY)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -749 Thousand USD | -199.43% |
| 2019 | 1.75 Million USD | 445.42% |
| 2018 | -506.9 Thousand USD | 15.08% |
| 2017 | -596.88 Thousand USD | 13.65% |
| 2016 | -691.21 Thousand USD | 7.91% |
| 2015 | -537 Thousand USD | -547.83% |
| 2014 | 305.79 Thousand USD | 111.49% |
| 2013 | -981.44 Thousand USD | 50.72% |
| 2012 | -1.56 Million USD | 8.26% |
| 2011 | -2.74 Million USD | -44.15% |
| 2010 | -4.51 Million USD | -28.71% |
| 2009 | -1.73 Million USD | 9.3% |
| 2008 | -1.91 Million USD | 13.68% |
| 2007 | -2.22 Million USD | 5.54% |
| 2006 | -2.25 Million USD | 17.43% |
| 2005 | -2.84 Million USD | -38.18% |
| 2004 | -2.06 Million USD | -797.63% |
| 2003 | -229.58 Thousand USD | 35.47% |
| 2002 | -355.76 Thousand USD | -2.68% |
| 2001 | -346.47 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | -494 Thousand USD | 70.42% |
| 2021 FY | - USD | 100.0% |
| 2021 Q1 | -378 Thousand USD | -6.48% |
| 2021 Q2 | -1.67 Million USD | -341.8% |
| 2020 Q4 | -355 Thousand USD | -22.41% |
| 2020 FY | - USD | -199.43% |
| 2020 Q2 | -773 Thousand USD | 49.01% |
| 2020 Q1 | -1.51 Million USD | -974.8% |
| 2020 Q3 | -290 Thousand USD | 62.48% |
| 2019 Q4 | -141.05 Thousand USD | 31.53% |
| 2019 FY | - USD | 445.42% |
| 2019 Q2 | 2.19 Million USD | 2272.95% |
| 2019 Q3 | -206 Thousand USD | -109.37% |
| 2019 Q1 | -101.19 Thousand USD | 26.47% |
| 2018 Q3 | -130.83 Thousand USD | -8.97% |
| 2018 FY | - USD | 15.08% |
| 2018 Q1 | -118.38 Thousand USD | 0.0% |
| 2018 Q2 | -120.05 Thousand USD | -1.41% |
| 2018 Q4 | -137.62 Thousand USD | -5.19% |
| 2017 FY | - USD | 13.65% |
| 2016 FY | - USD | 7.91% |
| 2016 Q4 | -121.53 Thousand USD | 23.16% |
| 2016 Q3 | -158.15 Thousand USD | -1931.59% |
| 2016 Q2 | -7785.00 USD | -100.99% |
| 2016 Q1 | 786.78 Thousand USD | 621.12% |
| 2015 Q1 | -181.55 Thousand USD | -180.88% |
| 2015 FY | - USD | -547.83% |
| 2015 Q4 | -150.98 Thousand USD | 39.48% |
| 2015 Q3 | -249.46 Thousand USD | -47.96% |
| 2015 Q2 | -168.6 Thousand USD | 7.13% |
| 2014 Q2 | 103.39 Thousand USD | 292.38% |
| 2014 Q3 | -186.59 Thousand USD | -280.47% |
| 2014 FY | - USD | 111.49% |
| 2014 Q4 | 224.45 Thousand USD | 220.29% |
| 2014 Q1 | 26.35 Thousand USD | 109.02% |
| 2013 Q4 | -292.21 Thousand USD | -206.33% |
| 2013 Q1 | -1.07 Million USD | -511.3% |
| 2013 Q3 | 274.83 Thousand USD | 175.58% |
| 2013 Q2 | -363.65 Thousand USD | 66.25% |
| 2013 FY | - USD | 50.72% |
| 2012 FY | - USD | 8.26% |
| 2012 Q1 | -901.19 Thousand USD | -14.37% |
| 2012 Q3 | -1.39 Million USD | -186.83% |
| 2012 Q2 | -486.35 Thousand USD | 46.03% |
| 2012 Q4 | -176.27 Thousand USD | 87.36% |
| 2011 Q2 | -1.11 Million USD | -48.87% |
| 2011 Q4 | -787.93 Thousand USD | -35.36% |
| 2011 Q3 | -582.09 Thousand USD | 47.58% |
| 2011 FY | - USD | -44.15% |
| 2011 Q1 | -745.86 Thousand USD | 59.94% |
| 2010 Q2 | 961.72 Thousand USD | 201.3% |
| 2010 FY | - USD | -28.71% |
| 2010 Q3 | -368.6 Thousand USD | -138.33% |
| 2010 Q4 | -1.86 Million USD | -405.06% |
| 2010 Q1 | -949.39 Thousand USD | -338.84% |
| 2009 Q4 | -216.34 Thousand USD | 60.41% |
| 2009 Q1 | -491.66 Thousand USD | -20.65% |
| 2009 Q2 | -484.5 Thousand USD | 1.46% |
| 2009 Q3 | -546.41 Thousand USD | -12.78% |
| 2009 FY | - USD | 9.3% |
| 2008 Q3 | -555.61 Thousand USD | -24.29% |
| 2008 Q1 | -507.18 Thousand USD | -1.18% |
| 2008 FY | - USD | 13.68% |
| 2008 Q4 | -407.5 Thousand USD | 26.66% |
| 2008 Q2 | -447.01 Thousand USD | 11.86% |
| 2007 Q2 | -572.47 Thousand USD | -2.29% |
| 2007 FY | - USD | 5.54% |
| 2007 Q4 | -501.26 Thousand USD | 16.13% |
| 2007 Q3 | -597.67 Thousand USD | -4.4% |
| 2007 Q1 | -559.64 Thousand USD | -58.69% |
| 2006 Q3 | -369.65 Thousand USD | 9.37% |
| 2006 Q4 | -352.66 Thousand USD | 4.59% |
| 2006 FY | - USD | 17.43% |
| 2006 Q1 | -1.22 Million USD | -243.38% |
| 2006 Q2 | -407.85 Thousand USD | 66.6% |
| 2005 Q4 | -355.61 Thousand USD | 58.49% |
| 2005 FY | - USD | -38.18% |
| 2005 Q1 | -870.14 Thousand USD | -2.75% |
| 2005 Q2 | -765.06 Thousand USD | 12.08% |
| 2005 Q3 | -856.75 Thousand USD | -11.99% |
| 2004 Q4 | -846.83 Thousand USD | -61.48% |
| 2004 Q3 | -524.43 Thousand USD | -22.91% |
| 2004 Q2 | -426.69 Thousand USD | -58.46% |
| 2004 Q1 | -269.28 Thousand USD | -133.6% |
| 2004 FY | - USD | -797.63% |
| 2003 Q3 | -55.51 Thousand USD | -93.48% |
| 2003 Q4 | -115.27 Thousand USD | -107.63% |
| 2003 Q2 | -28.69 Thousand USD | 5.33% |
| 2003 FY | - USD | 35.47% |
| 2003 Q1 | -1.37 Million USD | 68.07% |
| 2002 Q2 | -97.04 Thousand USD | -53.95% |
| 2002 Q4 | -94.93 Thousand USD | 5.8% |
| 2002 Q3 | -100.77 Thousand USD | -3.84% |
| 2002 FY | - USD | -2.68% |
| 2002 Q1 | -63.03 Thousand USD | 81.12% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | -5963.00 USD | 0.0% |
| 2001 Q4 | -333.87 Thousand USD | -5499.03% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 100.0% |
| Accelera Innovations, Inc | - USD | NaN% |
| Aspyra Inc. | -2.84 Million USD | 100.0% |
| Cannabis Sativa, Inc. | -1.11 Million USD | 100.0% |
| CompuMed, Inc. | 690.19 Thousand USD | 100.0% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.0% |
| Cogstate Limited | 9.89 Million USD | 100.0% |
| CareView Communications, Inc. | -210.04 Thousand USD | 100.0% |
| Craneware plc | 54.26 Million USD | 100.0% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 100.0% |
| Certive Solutions Inc. | -704.66 Thousand USD | 100.0% |
| Drug Free Solution, Inc. | -1.39 Million USD | 100.0% |
| DATATRAK International, Inc. | 2.72 Million USD | 100.0% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 100.0% |
| Healixa Inc. | -6.32 Million USD | 100.0% |
| Easy Technologies Inc. | - USD | NaN% |
| eWellness Healthcare Corporation | - USD | NaN% |
| Founders Bay Holdings | 10.16 Million USD | 100.0% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 100.0% |
| H-Source Holdings Ltd. | - USD | NaN% |
| InterCare DX, Inc. | - USD | NaN% |
| IQ-AI Limited | -370.35 Thousand USD | 100.0% |
| Cannabiz Mobile, Inc. | -750.00 USD | 100.0% |
| Mednow Inc. | -28.12 Million USD | 100.0% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | 100.0% |
| MediXall Group, Inc. | -6.52 Million USD | 100.0% |
| Mitesco, Inc. | -11.96 Million USD | 100.0% |
| MobileSmith, Inc. | -13.83 Million USD | 100.0% |
| NantHealth, Inc. | -38.53 Million USD | 100.0% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 100.0% |
| OneLife Technologies Corp. | - USD | NaN% |
| ORHub, Inc. | -12.08 Million USD | 100.0% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 100.0% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 100.0% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 100.0% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 100.0% |
| Renalytix Plc | -28.52 Million USD | 100.0% |
| Revium Recovery Inc. | -678 Thousand USD | 100.0% |
| RYAH Group, Inc. | - USD | NaN% |
| Carepay Inc. | -369.00 USD | 100.0% |
| Vaso Corporation | 4.19 Million USD | 100.0% |
| Vynleads, Inc. | -235.72 Thousand USD | 100.0% |